Subscribe
pavel-kapysh-lundbeck
Pavel Kapysh / Shutterstock.com
30 March 2021EuropeAlex Baldwin

Lundbeck loses €150m pay-for-delay appeal

Lundbeck has lost an appeal to the  Court of Justice of the European Union (CJEU) to waive €150 million ($176 million) in fines levied against itself and a group of five generics manufacturers over ‘pay-for-delay’ deals for its antidepressant generics.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Generics
Why the ‘first penguin’ of pay for delay has not come in Japan: anatomy of a Japan paradox
27 May 2022   Why does Japan have no reverse payments culture? Takanori Abe of Abe & Partners unpicks a complex issue.
Big Pharma
EU General Court backs Lundbeck fine in pay-for-delay case
12 September 2016   The EU General Court has backed the European Commission’s decision to fine pharma company Lundbeck and a number of generic producers.
Big Pharma
AG advises CJEU to uphold €94 million pay-for-delay fine
5 June 2020   The advocate general has recommended that the Court of Justice of the European Union uphold an almost €94 million fine imposed on Lundbeck for its pay-for-delay scheme.


Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024

More on this story

Generics
Why the ‘first penguin’ of pay for delay has not come in Japan: anatomy of a Japan paradox
27 May 2022   Why does Japan have no reverse payments culture? Takanori Abe of Abe & Partners unpicks a complex issue.
Big Pharma
EU General Court backs Lundbeck fine in pay-for-delay case
12 September 2016   The EU General Court has backed the European Commission’s decision to fine pharma company Lundbeck and a number of generic producers.
Big Pharma
AG advises CJEU to uphold €94 million pay-for-delay fine
5 June 2020   The advocate general has recommended that the Court of Justice of the European Union uphold an almost €94 million fine imposed on Lundbeck for its pay-for-delay scheme.

More on this story

Generics
Why the ‘first penguin’ of pay for delay has not come in Japan: anatomy of a Japan paradox
27 May 2022   Why does Japan have no reverse payments culture? Takanori Abe of Abe & Partners unpicks a complex issue.
Big Pharma
EU General Court backs Lundbeck fine in pay-for-delay case
12 September 2016   The EU General Court has backed the European Commission’s decision to fine pharma company Lundbeck and a number of generic producers.
Big Pharma
AG advises CJEU to uphold €94 million pay-for-delay fine
5 June 2020   The advocate general has recommended that the Court of Justice of the European Union uphold an almost €94 million fine imposed on Lundbeck for its pay-for-delay scheme.

More features

Bayer gains exclusive licence for heart drug in Japan
EPO delivers key Novo Nordisk, GSK and Inhibrx rulings
McGuireWoods expands team with ex-Novo Nordisk GC
Paul, Weiss swoops for senior duo from Weil, Gotshal
UPC bans Meril Life Sciences from selling infringing heart valve
SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic
Kathi Vidal to rejoin previous firm as partner following USPTO departure
GSK triumphs in EPO appeal, revoking Pfizer patent